Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

In n = 5 patients, hypothermia treatment was performed during surgery.Characteristics of SCFN in newbornsSubgroupsAll patients (n = 320)Normocalcaemia (n = 52)Hypercalcaemia (n = 146)Hypocalcaemia (n = 9)No information about calcium level (n = 113)Age at diagnosis of SCFN [days after birth]N297421368108mean ± SD11.3 ± 11.611.1 ± 9.111.8 ± 12.06.3 ± 5.811.4 ± 12.3Size of skin lesion (cm2)N832036126mean ± SD17.3 ± 38.119.0 ± 33.824.3 ± 50.33.8 ± 08.1 ± 9.8Symptoms at time of diagnosisN28522194663Radial paresisN (%)30 (10.5)1 (4.5)0 (0.0)0 (0.0)29 (46.0)Vomiting, diarrhoeaN (%)29 (10.2)1 (4.5)25 (12.9)0 (0.0)3 (4.8)Failure to thriveN (%)28 (9.8)1 (4.5)27 (13.9)0 (0.0)0 (0.0)FeverN (%)25 (8.8)3 (13.6)17 (8.7)0 (0.0)5 (7.9)Heart diseaseN (%)21 (7.4)6 (27.3)13 (6.7)2 (33.3)0 (0.0)Weight lossN (%)18 (6.3)1 (4.5)16 (8.2)0 (0.0)1 (1.6)Poor feeding (breast milk/formula)N (%)18 (6.3)2 (9)15 (7.7)0 (0.0)1 (1.6)Increased excitabilityN (%)17 (6.0)0 (0.0)16 (8.2)0 (0.0)1 (1.6)Muscular hypotoniaN (%)11 (3.9)0 (0.0)8 (4.1)1 (16.7)2 (3.2)LethargyN (%)11 (3.9)0 (0.0)8 (4.1)0 (0.0)3 (4.8)DehydrationN (%)10 (3.5)0 (0.0)8 (4.1)0 (0.0)3 (4.8)FurtheraN (%)37 (23.5)6 (27.3)41 (21.1)3 (50.0)17 (27.0)Serum calcium concentration [mmol/l]N: : 111: : Mean ± SD: : 3.6 ± 0.6: : Ionised calcium [mmol/l]N: : 19: : Mean ± SD: : 1.8 ± 1.0: : Vitamin D concentration (25(oH)D3) [ng/ml]N33: : : : Mean ± SD23.9 ± 15.8: : : : 1,25(OH)2D3 [pmol/l]N39: : : : Mean ± SD212.9 ± 135.3: : : : Parathormon concentration [pmol/l]N28: : : : Mean ± SD14.1 ± 38.5: : : : Serum triglycerid concentration [mg/dl]N182142: Mean ± SD346.3 ± 177.9214 ± 75383.3 ± 183.5219.2 ± 12.7: Time between diagnosis of SCFN and electrolyte disturbanceN122: 1148: Mean ± SD18.6 ± 32.2 to 19.3 ± 32.78.8 ± 24.0: Calcifications in relation to localisationN9758516KidneyN (%)46 (47.4)0 (0.0)45 (53.0)0 (0.0)1 (16.7)subcutanousN (%)36 (37.1)5 (100)26 (30.6)1 (100)4 (66.7)BrainN (%)4 (4.1)0 (0.0)4 (4.7)0 (0.0)0 (0.0)MyocardN (%)3 (3.1)0 (0.0)2 (2.4)0 (0.0)1 (16.7)LiverN (%)3 (3.1)0 (0.0)3 (3.5)0 (0.0)0 (0.0)Blood vesselsN (%)2 (2.1)0 (0.0)2 (2.4)0 (0.0)0 (0.0)StomachN (%)1 (1.0)0 (0.0)1 (1.2)0 (0.0)0 (0.0)BronchiaN (%)1 (1.0)0 (0.0)1 (1.2)0 (0.0)0 (0.0)MetaphysesN (%)1 (1.0)0 (0.0)1 (1.2)0 (0.0)0 (0.0)Symptoms and course of SCFNN1402665841duration until healing [days]Mean ± SD90.8 ± 65.190.8 ± 60.2100.6 ± 78.379.5 ± 43.977.3 ± 41.8

Source: Time of diagnosis. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology

Systematic review · Molecular and Cellular Pediatrics · 2022

Original publication title

Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology

Leonie Frank; Stephanie Brandt; Martin Wabitsch

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

We identified that maternal, birth characteristics and therapeutic measures are probably risk factors for SCFN. These risk factors should be taken into account within the care of neonates.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Subcutaneous fat necrosis of the newborn (SCFN) is a rare disease occurring in the first days of life. Characteristically, the infants show hard nodules in subcutaneous tissue, purple or erythematous in color and appear on the upper back, cheeks, buttocks and limbs. In most cases, SCFN is a self-limiting disease, as the nodules disappear in up to 6 months. A severe complication associated with SCFN is hypercalcaemia. Pathophysiological mechanisms causing SCFN or associated hypercalcaemia are not fully understood yet.

Source: Background

Abstract: What methods does the paper describe?

A systematic literature research including the six biggest databases for medical research has been used to identify all published case reports of SCFN. N = 206 publications has been identified containing n = 320 case reports. All cases have been classified into four subgroups (depending on reported serum-calcium-level): hypercalcaemia, normocalcaemia, hypocalcaemia or no information given. Reported maternal factors, birth characteristics, details about SCFN, diagnostics, therapy and long-term observations have been extracted from publications.

Source: Methods

Abstract: Results

This is the first systematic literature research that summed up all published cases of SCFN from 1948 up to 2018. Information about serum calcium level was given in 64.3% of the cases. From those, the majority showed hypercalcaemia (70.5%) (normocalcaemia 25.1%, hypocalcemia 4.3%). 89.3% of newborns with hypercalcaemia showed suppressed levels of the parathormone. Maternal gestational diabetes, maternal hypertensive diseases during pregnancy, macrosomia (> 4000g), asphyxia and therapeutic hypothermia are risk factors for SCFN. Histological findings showed a granulomatous inflammation in 98% of cases.

Source: Results

Abstract: Conclusion

We identified that maternal, birth characteristics and therapeutic measures are probably risk factors for SCFN. These risk factors should be taken into account within the care of neonates.

Source: Conclusion
Authors’ abstract

Background

Subcutaneous fat necrosis of the newborn (SCFN) is a rare disease occurring in the first days of life. Characteristically, the infants show hard nodules in subcutaneous tissue, purple or erythematous in color and appear on the upper back, cheeks, buttocks and limbs. In most cases, SCFN is a self-limiting disease, as the nodules disappear in up to 6 months. A severe complication associated with SCFN is hypercalcaemia. Pathophysiological mechanisms causing SCFN or associated hypercalcaemia are not fully understood yet.

Methods

A systematic literature research including the six biggest databases for medical research has been used to identify all published case reports of SCFN. N = 206 publications has been identified containing n = 320 case reports. All cases have been classified into four subgroups (depending on reported serum-calcium-level): hypercalcaemia, normocalcaemia, hypocalcaemia or no information given. Reported maternal factors, birth characteristics, details about SCFN, diagnostics, therapy and long-term observations have been extracted from publications.

Results

This is the first systematic literature research that summed up all published cases of SCFN from 1948 up to 2018. Information about serum calcium level was given in 64.3% of the cases. From those, the majority showed hypercalcaemia (70.5%) (normocalcaemia 25.1%, hypocalcemia 4.3%). 89.3% of newborns with hypercalcaemia showed suppressed levels of the parathormone. Maternal gestational diabetes, maternal hypertensive diseases during pregnancy, macrosomia (> 4000g), asphyxia and therapeutic hypothermia are risk factors for SCFN. Histological findings showed a granulomatous inflammation in 98% of cases.

Conclusion

We identified that maternal, birth characteristics and therapeutic measures are probably risk factors for SCFN. These risk factors should be taken into account within the care of neonates.

Supplementary Information

The online version contains supplementary material available at 10.1186/s40348-022-00151-1.

Publication and source details

Original title: Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology

Leonie Frank; Stephanie Brandt; Martin Wabitsch

Molecular and Cellular Pediatrics · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Universitätsklinikum Ulm (8941)

Open Access funding enabled and organized by Projekt DEAL.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T21:44:41.217408+00:00

DOI: 10.1186/s40348-022-00151-1 · PMC9700527